When reintroduced, PEDF (which is commonly downregulated in prostate cancer cells) decreased the rate of proton (H+) fluxes (function of V-ATPases) in metastatic prostate cancer cells without affecting it in non-metastatic counterparts [7]. The gene discussed is SERPINF1; the disease is prostate cancer.